Subscribe: Clinical Trials / Drug Trials News From Medical News Today
Added By: Feedage Forager Feedage Grade A rated
Language: English
cancer  cells  clinical trial  clinical trials  clinical  diabetes  drug  effective  found  new  research  study  treatment  trial 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Clinical Trials / Drug Trials News From Medical News Today

Clinical Trials / Drug Trials News From Medical News Today

Clinical trials are a type of research study to explore whether a medical treatment, drug, strategy or device is safe and effective for human use. The purpose of clinical trials is research, so the studies follow strict scientific standards. These standar

Copyright: Copyright 2017 Medical News Today

How cancer could be treated with an old alcoholism drug

Thu, 07 Dec 2017 00:00:00 PST

New research exposes the mechanism by which the anti-alcohol addiction drug disulfiram, also known as Antabuse, could be used to treat cancer.

Cannabinoid drug found effective for treating sleep apnea

Mon, 04 Dec 2017 00:00:00 PST

The largest and longest trial of a drug for obstructive sleep apnea finds the cannabinoid drug dronabinol safe and effective for treating the condition.

Migraine breakthrough: New drug halves attacks

Thu, 30 Nov 2017 08:00:00 PST

In a phase III clinical trial of people with episodic migraine, a drug called erenumab was found to cut the number of monthly migraine days by over half.

Malaria drugs could help to combat cancer

Fri, 24 Nov 2017 09:00:00 PST

Researchers reveal how two drugs used to treat malaria, called chloroquine and hydroxychloroquine, could help in the fight against cancer.

Diabetes: New compounds may lower blood sugar but prevent weight gain

Wed, 25 Oct 2017 10:00:00 PST

Current medications for insulin resistance may promote weight gain as a result of increased lipid production, but a new study may have found a solution.

Type 2 diabetes: Blood sugar pill shows promise

Tue, 17 Oct 2017 08:00:00 PST

In a 26-week phase II clinical trial for type 2 diabetes patients, glycemic control using semaglutide in pill form was better than using a placebo.

Cannabis intoxication may be stopped with anti-obesity drug

Mon, 09 Oct 2017 00:00:00 PST

Intoxication with so-called legal highs may be fatal. But new research may have found the antidote in a slimming drug that blocks cannabinoid receptors.

Heart failure could be treated using umbilical cord stem cells

Wed, 27 Sep 2017 00:00:00 PST

In the first study of its kind, researchers find that stem cells derived from the umbilical cord can be used to treat heart failure.

Poliovirus kills off cancer cells, stops tumor regrowth

Thu, 21 Sep 2017 00:00:00 PST

A modified poliovirus appears to trigger the body's anti-tumor immunity. The new study showed promising results in human breast cancer cells and mice.

Drug resistance: WHO report 'serious lack of new antibiotics'

Wed, 20 Sep 2017 09:00:00 PST

A new report from the WHO reveals that the current scope of new antibiotic development is far from what is needed to tackle drug resistance.

Sugarcane extract may relieve stress-induced insomnia

Sun, 10 Sep 2017 00:00:00 PST

Researchers find that octacosanol - a compound found in sugarcane, beeswax, and wheat germ oil - can restore stress-affected sleep in mice.

Reducing inflammation without lowering cholesterol cuts risk of cardiovascular events

Wed, 30 Aug 2017 00:00:00 PST

Inflammatory hypothesis confirmed: Landmark randomized clinical trial of high-risk patients finds that a drug targeting inflammation reduced risk of major adverse cardiovascular events.

Multiple sclerosis: Are we close to a cure?

Mon, 21 Aug 2017 08:00:00 PST

Discoveries and breakthroughs in multiple sclerosis research are building momentum, but just how close are we to finding a cure? We investigate.

Osteoporosis: Potential new drug target uncovered

Mon, 21 Aug 2017 08:00:00 PST

A new study finds that targeting the body's aging-related cells maintains and increases bone formation and improves bone mass and strength in aging mice.

Peanut allergy could be cured with probiotics

Fri, 18 Aug 2017 09:00:00 PST

The vast majority of children in a large clinical trial continued to tolerate peanuts for 4 years after it had ended, new research shows.

Reversing brain death: Far-fetched or feasible?

Fri, 18 Aug 2017 08:00:00 PST

Ira Pastor, CEO of Bioquark, Inc., speaks to MNT about his team's controversial plans to restore life to people who have been declared brain dead.

'Accelerated approval' drugs: How well are they studied?

Thu, 17 Aug 2017 00:00:00 PST

When an investigational prescription drug shows promise for treating a serious illness or filling an unmet medical need, the Food and Drug Administration (FDA) has special programs available to...

Prostate cancer: Study identifies earlier clinical trial endpoint that can be used to indicate effectiveness of new treatments

Wed, 16 Aug 2017 00:00:00 PST

Scientists say they have validated a "surrogate endpoint" - a reliable statistical shortcut in a clinical trial - that could accelerate testing of new adjuvant therapies aimed at reducing deaths from...

Immunotherapy found safe for type 1 diabetes in landmark trial

Thu, 10 Aug 2017 00:00:00 PST

A new trial investigates the safety profile of proinsulin peptide immunotherapy for treating type 1 diabetes, and the results are encouraging.

Could vitamin B-3 help to prevent melanoma?

Wed, 09 Aug 2017 08:00:00 PST

A new review suggests that nicotinamide - a form of vitamin B-3 - could be a promising candidate for the prevention of melanoma, the deadliest skin cancer.

Diabetes shot boosts motor function for patients with Parkinson's

Fri, 04 Aug 2017 08:00:00 PST

A placebo trial shows that the diabetes drug exenatide improved motor symptoms of Parkinson's disease and may have disease-altering potential.

New compound boosts treatment for aggressive breast cancer

Thu, 03 Aug 2017 00:00:00 PST

A new anticancer agent, if given in combination with existing treatment, proves highly effective against triple negative and HER2 positive breast cancers.

Melanoma: New, more effective drug steps closer

Fri, 28 Jul 2017 08:00:00 PST

Scientists have designed and tested a new compound that they think will succeed where current drugs against melanoma have failed.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

Fri, 28 Jul 2017 00:00:00 PST

A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for...

Experimental HIV vaccine regimen is well-tolerated, elicits immune responses

Wed, 26 Jul 2017 00:00:00 PST

Results from an early-stage clinical trial called APPROACH show that an investigational HIV vaccine regimen was well-tolerated and generated immune responses against HIV in healthy adults.